Effects of Propofol-Induced Anaesthesia on the ST-segment of the ECG
Prop ST
1 other identifier
observational
500
1 country
1
Brief Summary
The purpose of this study is to assess the effect of propofol induced general anaesthesia on the ST-segment of the electrocardiogram. This will be realised by retrospectively analysing the ECG-recordings from adult patients undergoing any treatment at the Catheterisation Laboratory. The ST-segment and other ECG measurements from induction of anaesthesia up to 20 minutes later, will be assessed and compared to the baseline values of the respective segments acquired before injecting propofol. It is essential in this study to exclude any patients burdened with the diagnosis, suspicion or family history of Brugada syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2021
CompletedFirst Posted
Study publicly available on registry
January 11, 2022
CompletedStudy Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedFebruary 23, 2022
December 1, 2021
2 months
December 22, 2021
February 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
ST-segment variations after propofol administration.
Determine ST-segment variations in mm (either augmentation or suppression) on the ECG in the 20 minute period after administration of propofol in comparison to the baseline ECG
Baseline ECG will be measured before administration of propofol. ECG will be measured in the 20 minutes following administration of propofol
Secondary Outcomes (1)
Additional ECG-segment variations after propofol administration
Baseline ECG will be measured before administration of propofol. ECG will be measured in the 20 minutes following administration of propofol
Study Arms (1)
non-Brugada population
Adult patients who underwent general anaesthesia (with propofol as induction agent) at the catheterisation laboratory of the UZ Brussel
Interventions
Eligibility Criteria
Adult patients who underwent a surgical procedure under propofol-based general anaesthesia in the CathLab of UZB.
You may qualify if:
- Induction of anaesthesia with propofol
- Monitored anaesthesia in the CathLab of the Universitair Ziekenhuis Brussel
You may not qualify if:
- Brugada Syndrome or family history of Brugada syndrome
- Paediatric population (age \<18)
- Patients who did not receive propofol during the procedure
- Patients who presented with fever (central core temperature \>38,0°C)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitair Ziekenhuis Brussel
Brussels, Brussels Capital, 1090, Belgium
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2021
First Posted
January 11, 2022
Study Start
February 1, 2022
Primary Completion
April 1, 2022
Study Completion
April 1, 2022
Last Updated
February 23, 2022
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share